Meilin Jiang Selected Research

Nivolumab

1/2020

Peripheral Blood Biomarkers Associated With Outcome in Non-small Cell Lung Cancer Patients Treated With Nivolumab and Durvalumab Monotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meilin Jiang Research Topics

Disease

4	Neoplasms (Cancer) 03/2021 - 01/2020
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2021 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 03/2024 - 01/2021
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 03/2020
2	Lung Neoplasms (Lung Cancer) 03/2021 - 12/2020
2	Neoplasm Metastasis (Metastasis) 03/2021 - 01/2021
1	Adenocarcinoma of Lung 01/2022
1	Primitive Neuroectodermal Tumors (PNET) 01/2022
1	Disease Progression 01/2021
1	Confusion (Bewilderment) 01/2020

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 12/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2021
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2021
1	Blood Glucose (Blood Sugar)IBA 03/2024
1	Immune Checkpoint InhibitorsIBA 03/2021
1	dacomitinibIBA 01/2021
1	Lipid NanoparticlesIBA 12/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2020
1	Small Interfering RNA (siRNA)IBA 12/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	NivolumabIBA 01/2020
1	durvalumabIBA 01/2020

Therapy/Procedure

5	Therapeutics 01/2022 - 03/2020
2	Immunotherapy 03/2021 - 03/2020
1	Fitness Trackers 01/2021
1	Drug Therapy (Chemotherapy) 12/2020